Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

JYNT vs USPH vs ENSG vs ACHC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
JYNT
The Joint Corp.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$124M
5Y Perf.-42.5%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$897M
5Y Perf.-20.0%
ENSG
The Ensign Group, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$10.18B
5Y Perf.+327.0%
ACHC
Acadia Healthcare Company, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$2.25B
5Y Perf.-12.0%

JYNT vs USPH vs ENSG vs ACHC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
JYNT logoJYNT
USPH logoUSPH
ENSG logoENSG
ACHC logoACHC
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$124M$897M$10.18B$2.25B
Revenue (TTM)$57M$695M$5.27B$3.37B
Net Income (TTM)$3M$11M$363M$-1.11B
Gross Margin78.5%22.0%15.2%56.2%
Operating Margin1.1%12.2%8.5%11.7%
Forward P/E44.9x20.6x23.2x16.4x
Total Debt$2M$426M$4.15B$2.65B
Cash & Equiv.$24M$36M$504M$133M

JYNT vs USPH vs ENSG vs ACHCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

JYNT
USPH
ENSG
ACHC
StockMay 20May 26Return
The Joint Corp. (JYNT)10057.5-42.5%
U.S. Physical Thera… (USPH)10080.0-20.0%
The Ensign Group, I… (ENSG)100427.0+327.0%
Acadia Healthcare C… (ACHC)10088.0-12.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: JYNT vs USPH vs ENSG vs ACHC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ENSG leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. U.S. Physical Therapy, Inc. is the stronger pick specifically for dividend income and shareholder returns. ACHC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
JYNT
The Joint Corp.
The Secondary Option

JYNT lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
USPH
U.S. Physical Therapy, Inc.
The Income Pick

USPH is the #2 pick in this set and the best alternative if dividends is your priority.

  • 3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Best for: dividends
ENSG
The Ensign Group, Inc.
The Income Pick

ENSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 12 yrs, beta 0.42, yield 0.1%
  • Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
  • 7.5% 10Y total return vs USPH's 22.6%
  • Lower volatility, beta 0.42, current ratio 1.42x
Best for: income & stability and growth exposure
ACHC
Acadia Healthcare Company, Inc.
The Value Play

ACHC is the clearest fit if your priority is value.

  • Lower P/E (16.4x vs 23.2x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthENSG logoENSG18.7% revenue growth vs ACHC's 5.0%
ValueACHC logoACHCLower P/E (16.4x vs 23.2x)
Quality / MarginsENSG logoENSG6.9% margin vs ACHC's -32.8%
Stability / SafetyENSG logoENSGBeta 0.42 vs JYNT's 0.98
DividendsUSPH logoUSPH3.1% yield, 5-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend)
Momentum (1Y)ENSG logoENSG+27.5% vs USPH's -14.3%
Efficiency (ROA)ENSG logoENSG6.8% ROA vs ACHC's -18.6%, ROIC 7.0% vs 5.9%

JYNT vs USPH vs ENSG vs ACHC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

JYNTThe Joint Corp.
FY 2025
Royalty
60.5%$33M
Advertising
19.0%$10M
Technology Service
11.0%$6M
Franchise
6.1%$3M
Product and Service, Other
3.3%$2M
USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M
ENSGThe Ensign Group, Inc.
FY 2025
Skilled Services Segment
97.4%$4.8B
Standard Bearer Segment
2.6%$127M
ACHCAcadia Healthcare Company, Inc.
FY 2025
United States Facilities
100.0%$3.3B

JYNT vs USPH vs ENSG vs ACHC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJYNTLAGGINGUSPH

Income & Cash Flow (Last 12 Months)

Evenly matched — JYNT and USPH and ENSG each lead in 2 of 6 comparable metrics.

ENSG is the larger business by revenue, generating $5.3B annually — 93.1x JYNT's $57M. ENSG is the more profitable business, keeping 6.9% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…
RevenueTrailing 12 months$57M$695M$5.3B$3.4B
EBITDAEarnings before interest/tax$2M$107M$558M$588M
Net IncomeAfter-tax profit$3M$11M$363M-$1.1B
Free Cash FlowCash after capex$3M$67M$406M-$215M
Gross MarginGross profit ÷ Revenue+78.5%+22.0%+15.2%+56.2%
Operating MarginEBIT ÷ Revenue+1.1%+12.2%+8.5%+11.7%
Net MarginNet income ÷ Revenue+5.7%+1.5%+6.9%-32.8%
FCF MarginFCF ÷ Revenue+4.7%+9.6%+7.7%-6.4%
Rev. Growth (YoY)Latest quarter vs prior year+13.3%+7.7%+18.4%+7.6%
EPS Growth (YoY)Latest quarter vs prior year+71.4%-115.0%+21.9%-49.8%
Evenly matched — JYNT and USPH and ENSG each lead in 2 of 6 comparable metrics.

Valuation Metrics

ACHC leads this category, winning 5 of 6 comparable metrics.

At 29.8x trailing earnings, ENSG trades at a 35% valuation discount to JYNT's 45.6x P/E. On an enterprise value basis, ACHC's 8.3x EV/EBITDA is more attractive than JYNT's 126.9x.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…
Market CapShares × price$124M$897M$10.2B$2.3B
Enterprise ValueMkt cap + debt − cash$103M$1.3B$13.8B$4.8B
Trailing P/EPrice ÷ TTM EPS45.63x41.55x29.85x-2.01x
Forward P/EPrice ÷ next-FY EPS est.44.85x20.63x23.19x16.42x
PEG RatioP/E ÷ EPS growth rate2.16x
EV / EBITDAEnterprise value multiple126.93x12.52x25.71x8.27x
Price / SalesMarket cap ÷ Revenue2.26x1.15x2.01x0.68x
Price / BookPrice ÷ Book value/share8.70x1.16x4.59x1.04x
Price / FCFMarket cap ÷ FCF370.99x14.71x27.46x
ACHC leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

JYNT leads this category, winning 5 of 9 comparable metrics.

JYNT delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-41 for ACHC. JYNT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x. On the Piotroski fundamental quality scale (0–9), JYNT scores 6/9 vs ACHC's 5/9, reflecting solid financial health.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…
ROE (TTM)Return on equity+16.9%+1.4%+16.6%-40.9%
ROA (TTM)Return on assets+5.0%+0.9%+6.8%-18.6%
ROICReturn on invested capital+5.6%+7.0%+5.9%
ROCEReturn on capital employed-2.9%+7.6%+10.2%+7.5%
Piotroski ScoreFundamental quality 0–96555
Debt / EquityFinancial leverage0.13x0.55x1.86x1.24x
Net DebtTotal debt minus cash-$22M$390M$3.7B$2.5B
Cash & Equiv.Liquid assets$24M$36M$504M$133M
Total DebtShort + long-term debt$2M$426M$4.2B$2.7B
Interest CoverageEBIT ÷ Interest expense15.42x88.33x-5.99x
JYNT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ENSG leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $1,608 for JYNT. Over the past 12 months, ENSG leads with a +27.5% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs ACHC's -29.2% — a key indicator of consistent wealth creation.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…
YTD ReturnYear-to-date-2.0%-24.6%+0.3%+71.2%
1-Year ReturnPast 12 months-12.8%-14.3%+27.5%+1.2%
3-Year ReturnCumulative with dividends-41.0%-43.7%+88.9%-64.5%
5-Year ReturnCumulative with dividends-83.9%-43.4%+103.2%-61.8%
10-Year ReturnCumulative with dividends+191.9%+22.6%+752.0%-58.5%
CAGR (3Y)Annualised 3-year return-16.1%-17.4%+23.6%-29.2%
ENSG leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ENSG and ACHC each lead in 1 of 2 comparable metrics.

ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than JYNT's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACHC currently trades 81.0% from its 52-week high vs USPH's 63.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…
Beta (5Y)Sensitivity to S&P 5000.94x1.00x0.42x0.84x
52-Week HighHighest price in past year$13.47$93.50$218.00$30.20
52-Week LowLowest price in past year$7.50$58.55$133.81$11.43
% of 52W HighCurrent price vs 52-week peak+64.4%+63.1%+80.0%+81.0%
RSI (14)Momentum oscillator 0–10049.346.123.346.2
Avg Volume (50D)Average daily shares traded57K171K358K3.1M
Evenly matched — ENSG and ACHC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.

Analyst consensus: JYNT as "Buy", USPH as "Buy", ENSG as "Buy", ACHC as "Buy". Consensus price targets imply 130.7% upside for JYNT (target: $20) vs -3.9% for ACHC (target: $24). For income investors, USPH offers the higher dividend yield at 3.06% vs ENSG's 0.14%.

MetricJYNT logoJYNTThe Joint Corp.USPH logoUSPHU.S. Physical The…ENSG logoENSGThe Ensign Group,…ACHC logoACHCAcadia Healthcare…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$20.00$102.00$222.33$23.50
# AnalystsCovering analysts8121325
Dividend YieldAnnual dividend ÷ price+3.1%+0.1%
Dividend StreakConsecutive years of raises5121
Dividend / ShareAnnual DPS$1.80$0.24
Buyback YieldShare repurchases ÷ mkt cap+9.1%+0.6%+0.2%+2.2%
Evenly matched — USPH and ENSG each lead in 1 of 2 comparable metrics.
Key Takeaway

ACHC leads in 1 of 6 categories (Valuation Metrics). JYNT leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallThe Joint Corp. (JYNT)Leads 1 of 6 categories
Loading custom metrics...

JYNT vs USPH vs ENSG vs ACHC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is JYNT or USPH or ENSG or ACHC a better buy right now?

For growth investors, The Ensign Group, Inc.

(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). The Ensign Group, Inc. (ENSG) offers the better valuation at 29. 8x trailing P/E (23. 2x forward), making it the more compelling value choice. Analysts rate The Joint Corp. (JYNT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — JYNT or USPH or ENSG or ACHC?

On trailing P/E, The Ensign Group, Inc.

(ENSG) is the cheapest at 29. 8x versus The Joint Corp. at 45. 6x. On forward P/E, Acadia Healthcare Company, Inc. is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — JYNT or USPH or ENSG or ACHC?

Over the past 5 years, The Ensign Group, Inc.

(ENSG) delivered a total return of +103. 2%, compared to -83. 9% for The Joint Corp. (JYNT). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus ACHC's -58. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — JYNT or USPH or ENSG or ACHC?

By beta (market sensitivity over 5 years), The Ensign Group, Inc.

(ENSG) is the lower-risk stock at 0. 42β versus U. S. Physical Therapy, Inc. 's 1. 00β — meaning USPH is approximately 138% more volatile than ENSG relative to the S&P 500. On balance sheet safety, The Joint Corp. (JYNT) carries a lower debt/equity ratio of 13% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — JYNT or USPH or ENSG or ACHC?

By revenue growth (latest reported year), The Ensign Group, Inc.

(ENSG) is pulling ahead at 18. 7% versus 5. 0% for Acadia Healthcare Company, Inc. (ACHC). On earnings-per-share growth, the picture is similar: The Joint Corp. grew EPS 133. 9% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — JYNT or USPH or ENSG or ACHC?

The Ensign Group, Inc.

(ENSG) is the more profitable company, earning 6. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACHC leads at 11. 7% versus -1. 6% for JYNT. At the gross margin level — before operating expenses — JYNT leads at 76. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is JYNT or USPH or ENSG or ACHC more undervalued right now?

On forward earnings alone, Acadia Healthcare Company, Inc.

(ACHC) trades at 16. 4x forward P/E versus 44. 9x for The Joint Corp. — 28. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JYNT: 130. 7% to $20. 00.

08

Which pays a better dividend — JYNT or USPH or ENSG or ACHC?

In this comparison, USPH (3.

1% yield), ENSG (0. 1% yield) pay a dividend. JYNT, ACHC do not pay a meaningful dividend and should not be held primarily for income.

09

Is JYNT or USPH or ENSG or ACHC better for a retirement portfolio?

For long-horizon retirement investors, The Ensign Group, Inc.

(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, ACHC: -58. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between JYNT and USPH and ENSG and ACHC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: JYNT is a small-cap quality compounder stock; USPH is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; ACHC is a small-cap quality compounder stock. USPH pays a dividend while JYNT, ENSG, ACHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

JYNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 5%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Stocks Like

ENSG

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 5%
Run This Screen
Stocks Like

ACHC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 33%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform JYNT and USPH and ENSG and ACHC on the metrics below

Revenue Growth>
%
(JYNT: 13.3% · USPH: 7.7%)
P/E Ratio<
x
(JYNT: 45.6x · USPH: 41.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.